Search Within

Zhaohua Hou

Formats
  1. Review (4)
  2. Meeting Abstract (3)
  3. Editorial (1)
  4. Journal Article (1)
Groups
  1. Sloan Kettering Institute Postdocs (9)
  2. Surgery (7)
  3. Center for Hematologic Malignancies (2)
  4. Department of Medicine (2)
  5. GSK Faculty (2)
  6. Hematologic Malignancies Research (2)

More Groups

People
  1. Prasad Adusumilli (7)
  2. Alfredo Amador Molina (5)
  3. Navin Chintala (4)
  4. Jasmeen Saini (3)
  5. Rebecca Bellis (3)
  6. Srijita Banerjee (3)

More People

Years
  1. 2025 (1)
  2. 2023 (2)
  3. 2022 (3)
  4. 2021 (2)
  5. 2020 (1)
Publications
  1. Frontiers in Immunology (2)
  2. Annals of Oncology (1)
  3. Cancer Cell (1)
  4. Cancer Research (1)
  5. Expert Opinion on Investigational Drugs (1)
  6. Journal of Immunology (1)

More Publications

Publishers
  1. Frontiers Media S.A. (2)
  2. American Association for Cancer Research (1)
  3. Cell Press (1)
  4. Elsevier Inc. (1)
  5. Nature Research (1)
  6. Oxford University Press (1)

More Publishers

Results (9)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Combinational CAR T-cell therapy for solid tumors: Requisites, rationales, and trials
    Review

    Misawa, K.; Bhat, H.; Adusumilli, P. S.; Hou, Z.
    Pharmacology & Therapeutics (2025)

    Fulltext@MSK | Save
  • CAR T-cell intrinsic PD1 dominant negative receptor (PD1DNR) functions by both cell-intrinsic and extrinsic mechanisms
    Meeting Abstract

    Amador, A.; Hou, Z.; Chintala, N.; Adusumilli, P. S.
    Journal of Immunology (2023)

    Fulltext@MSK | Save
  • c-Kit signaling potentiates CAR T cell efficacy in solid tumors by CD28- and IL-2-independent co-stimulation
    Journal Article

    Xiong, Y.; Taleb, M.; Misawa, K.; Hou, Z.; Banerjee, S.; Amador-Molina, A.; Jones, D. R.; Chintala, N. K.; Adusumilli, P. S.
    Nature Cancer (2023)

    Fulltext@MSK | Save
  • Targeting T-cell metabolism to boost immune checkpoint inhibitor therapy
    Review

    Li, H.; Zhao, A.; Li, M.; Shi, L.; Han, Q.; Hou, Z.
    Frontiers in Immunology (2022)

    Fulltext@MSK | Save
  • Next-generation immunotherapy for solid tumors: Combination immunotherapy with crosstalk blockade of TGFβ and PD-1/PD-L1
    Review

    Quach, H. T.; Hou, Z.; Bellis, R. Y.; Saini, J. K.; Amador-Molina, A.; Adusumilli, P. S.; Xiong, Y.
    Expert Opinion on Investigational Drugs (2022)

    Fulltext@MSK | Save
  • Regional CAR T cell therapy: An ignition key for systemic immunity in solid tumors
    Editorial

    Cherkassky, L.; Hou, Z.; Amador-Molina, A.; Adusumilli, P. S.
    Cancer Cell (2022)

    Fulltext@MSK | Save
  • Promoting functional persistence in solid tumor CAR T-cell therapy: Mesothelin-targeted CAR (M28z1XXPD1DNR) with T-cell intrinsic PD1 dominant negative receptor
    Meeting Abstract

    Adusumilli, P. S.; Amador, A. M.; Chintala, N.; Hou, Z.; Offin, M.; Pineda, J.; Senechal, B.; Quach, H. T.; Bellis, R.; Banerjee, S.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • Do engineered nanomaterials affect immune responses by interacting with gut microbiota?
    Review

    Tang, M.; Li, S.; Wei, L.; Hou, Z.; Qu, J.; Li, L.
    Frontiers in Immunology (2021)

    Fulltext@MSK | Save
  • Regional delivery of clinical-grade mesothelin-targeted CAR T cells with cell-intrinsic PD-1 checkpoint blockade: Translation to a phase I trial
    Meeting Abstract

    Kiesgen, S.; Linot, C.; Quach, H. T.; Saini, J.; Bellis, R.; Banerjee, S.; Hou, Z.; Chintala, N. K.; Sadelain, M.; Adusumilli, P. S.
    Cancer Research (2020)

    Fulltext@MSK | Save